Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Protalix Biotherapeutics
(NY:
PLX
)
1.090
UNCHANGED
Official Closing Price
Updated: 8:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
74,901
Open
1.080
Bid (Size)
1.090 (20)
Ask (Size)
1.150 (1)
Prev. Close
1.090
Today's Range
1.079 - 1.100
52wk Range
0.8214 - 1.900
Shares Outstanding
73,542,674
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm
September 17, 2024
From
Kaskela Law LLC
Via
Business Wire
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
September 16, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Performance
YTD
-40.11%
-40.11%
1 Month
N/A
N/A
3 Month
-0.91%
-0.91%
6 Month
-5.22%
-5.22%
1 Year
-25.34%
-25.34%
More News
Read More
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Beats Revenue for Q2 2024
August 14, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 17, 2024
Via
Benzinga
Earnings Preview: Protalix BioTherapeutics
March 13, 2024
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Via
Benzinga
Earnings Preview For Protalix BioTherapeutics
November 03, 2023
Via
Benzinga
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024
May 10, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
Pullix Gains Momentum As Gamestop Exits NFT Space
January 14, 2024
Via
Talk Markets
Protalix BioTherapeutics And 2 Other Penny Stocks Insiders Are Buying
October 23, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via
Benzinga
Preview: Protalix BioTherapeutics's Earnings
August 04, 2023
Via
Benzinga
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
May 10, 2023
Via
Benzinga
Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil
May 04, 2023
Via
Benzinga
Earnings Preview For Protalix BioTherapeutics
February 24, 2023
Via
Benzinga
Looking Into Protalix BioTherapeutics's Return On Capital Employed
December 23, 2022
Via
Benzinga
Protalix BioTherapeutics Well Placed to Advance in 2023
December 12, 2022
Via
Talk Markets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 10, 2023
Via
InvestorPlace
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
February 27, 2023
Via
Benzinga
$12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying
January 06, 2023
Via
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Via
Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via
News Direct
Exposures
Product Safety
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via
TheNewswire.com
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
